blood; platelets
-
not specified
RT-qPCR; Clinical Sample Validation; ROC Analysis
hsa_circ_0019120 showed diagnostic potential for distinguishing advanced polyp and CRC patients from healthy controls, with AUC of 0.739 for advanced polyps and 0.717 for CRC; combined with hsa_circ_0004771, AUC was 0.8348 with sensitivity of 84% and specificity of 80%.
Platelet-derived hsa_circ_0019120 was significantly upregulated in both advanced polyp patients and CRC patients compared with healthy controls. The study supports its potential as a non-invasive biomarker for CRC and advanced polyp risk assessment and early detection, including combined diagnostic use with hsa_circ_0004771.
0.4187
Platelet-Derived circRNAs hsa_circ_0004771 and hsa_circ_0019120 Differentially Expressed in Colorectal Cancer and Polyps.
clinical study